Diabetes Care Journal
Overview
Publication venue for
- Editorial Cycles and Continuity of Diabetes Care. 45:1493-1494. 2022
- Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. 45:372-380. 2022
- Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. 45:372-380. 2022
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial. 45:E3-E6. 2021
- Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial. 45:E3-E6. 2021
- A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes. 44:8-10. 2020
- Visit-to-Visit Hemoglobin A(1c)Variability Is Associated With the Risk of Lower-Extremity Amputation in Patients With Type 2 Diabetes. 43:E178-E180. 2020
- Visit-to-Visit Hemoglobin A(1c)Variability Is Associated With the Risk of Lower-Extremity Amputation in Patients With Type 2 Diabetes. 43:E178-E180. 2020
- Diabetes Care Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care. 42:1136-1146. 2019
- Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. 42:2108-2116. 2019
- Big Topics for Diabetes Care in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology. 41:1327-1329. 2018
- Diabetes Care: "Taking It to the Limit One More Time". 40:3-6. 2017
- Building Momentum: Taking on the Real "Issues" of Diabetes Care!. 39:10-12. 2016
- Diabetes Care: "Lagniappe" and "Seeing Is Believing"!. 39:1069-1071. 2016
- Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". 39:664-667. 2016
- Status of Diabetes Care: New Challenges, New Concepts, New MeasuresFocusing on the Future!. 38:1177-1180. 2015
- Fitness, Fatness, and Survival in Adults With Prediabetes. 37:529-536. 2014
- Status of Diabetes Care: "It Just Doesn't Get Any Better ... or Does It?". 37:1782-1785. 2014
- Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin. 36:3517-3525. 2013
- Categorical Analysis of the Impact of Aerobic and Resistance Exercise Training, Alone and in Combination, on Cardiorespiratory Fitness Levels in Patients With Type 2 Diabetes Results from the HART-D study. 36:3305-3312. 2013
- Changes in Body Fat Distribution and Fitness Are Associated With Changes in Hemoglobin A(1c) After 9 Months of Exercise Training: Results from the HART-D study. 36:2843-2849. 2013
- The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes. 36:858-864. 2013
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents. 33:1300-1303. 2010
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD). 32:1224-1230. 2009
Identity
International Standard Serial Number (ISSN)
- 0149-5992